Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
<jats:title>Abstract</jats:title><jats:p>Transfer of convalescent plasma (CP) had been proposed early during the SARS-CoV-2 pandemic as an accessible therapy, yet trial results worldwide have been mixed, potentially due to the heterogeneous nature of CP. Here we perform deep profil...
Glavni autori: | , , , , , , , , , , , , , , |
---|---|
Daljnji autori: | |
Format: | Članak |
Jezik: | English |
Izdano: |
Springer Science and Business Media LLC
2023
|
Online pristup: | https://hdl.handle.net/1721.1/147864 |